Karnataka HC: Health Insurance No Hospitalization Claim Upheld for Cancer

• The Karnataka High Court upheld a Permanent Lok Adalat's award concerning a health insurance claim.
• National Insurance Co. Ltd. was directed to reimburse a retired bank officer for cancer-related Zoladex and Xgeva injections.
• The insurer had initially rejected the claim because the treatment did not require hospitalization.
• The court ruled that denying a claim solely for lack of hospitalization defeats the purpose of health insurance.
• This decision sets a precedent for health insurance claims involving non-hospitalization treatments in India.

The Karnataka High Court health insurance ruling emphasized that denying a claim solely on the basis that the treatment did not require an inpatient stay would fundamentally undermine the very purpose of health insurance.

A retired bank officer initiated a claim against National Insurance Co. Ltd. seeking reimbursement for critical cancer-related treatments. The officer had undergone a specific regimen involving Zoladex and Xgeva injections, which are crucial for managing certain types of cancer. However, the insurance provider, National Insurance Co. Ltd., rejected the claim, asserting that the treatment did not necessitate hospitalization, thereby falling outside the scope of their coverage.

This initial denial prompted the retired officer to seek recourse through the Permanent Lok Adalat. The Lok Adalat, after reviewing the specifics of the case and the nature of the medical treatment, ruled in favor of the policyholder. It determined that the insurance company was obligated to reimburse the costs associated with the cancer injections, setting a precedent that challenged the insurer's interpretation of its policy terms regarding non-hospitalization treatments.

The Karnataka High Court subsequently reviewed the Permanent Lok Adalat's decision, which had directed National Insurance Co. Ltd. to provide coverage for the cancer treatment. In a significant affirmation, the High Court upheld the Lok Adalat's award, thereby reinforcing the policyholder's right to reimbursement for the Zoladex and Xgeva injections. The court's judgment directly addressed the insurer's primary argument that the absence of hospitalization justified the claim rejection.

The Karnataka High Court health insurance ruling emphasized that denying a claim solely on the basis that the treatment did not require an inpatient stay would fundamentally undermine the very purpose of health insurance. This interpretation underscores the principle that health insurance is intended to cover necessary medical expenses, irrespective of whether they are incurred within a hospital setting or through outpatient procedures, especially for critical conditions like cancer. The court's stance on this National Insurance Co. Ltd claim provides crucial clarity on what constitutes a valid claim under health insurance policies in India.

This landmark decision by the Karnataka High Court has profound implications for health insurance claim non-hospitalization cases across the country. It establishes a strong precedent against the arbitrary rejection of claims for essential medical treatments that do not mandate an overnight hospital stay. The ruling particularly benefits patients requiring expensive, life-saving injections or other outpatient procedures, ensuring that their Zoladex Xgeva insurance coverage, or similar treatments, are not denied based on a narrow interpretation of policy terms.

The judgment serves as a critical reminder to insurance providers that the core objective of health insurance is to provide financial protection for medical necessities. It challenges the prevailing practice of some insurers to reject claims based on the lack of hospitalization, especially when such treatments are medically advised and effective. This ruling is expected to influence how future India insurance claim rejection cases are handled, potentially leading to a more consumer-centric approach in the assessment of health insurance claims.

This ruling provides a strong precedent for lawyers to challenge health insurance claim rejections based solely on the absence of hospitalization, particularly for treatments like injections. Compliance officers in insurance firms should review their claim assessment protocols to align with this interpretation of consumer protection.

Source: Original reporting via Live Law